Фундаментал ва клиник тиббиёт ахборотномаси , 2024, №6 (12)

Maqola mavzusi

O’TKIR RINOSINUSITLARDA FITOTERAPEVTIK DAVO SAMARADORLIGI (46-51)

Mualliflar

Nurov U.I., Boboqulova D. F.

Muassasa

Buxoro davlat tibbiyot instituti

Annotatsiya

Maqolada eng dolzarb LOR organlari, ya'ni o'tkir rinosinusitlar yallig'lanish kasalliklarini davolashda o'simlik dori vositalaridan foydalanish muammosi yoritilgan. LOR kasalliklarining o'simlik dori-darmonlari bilan davolash shifokorlar va bemorlarni har doim o'ziga jalb qilib kelgan. Biroq, dalillarga asoslangan tibbiyot nuqtai nazaridan, ko'pchilik fitopreparatlarga - ishonchlilik, yaxshi nazorat qilinadigan tadqiqotlarning kamligi tufayli ko'plab savollar paydo bo’ladi. Ushbu maqolada o'tkir rinosinusitni davolashda o'simlik dori-darmonlari bo'yicha dalillarga asoslangan tadqiqotlar ma'lumotlari keltirilgan.Fitopreparatlarning sekretolitik, sekretomotor, yallig'lanishga qarshi, o'rtacha antibakterial va antivirus ta'siri mavjud.Fitopreparatlarning umumiy farmakologik xususiyat o'simliklarning bir qismi ekssudatsiya fazasini blokirovka qilish va qon tomir devori o'tkazuvchanlikni kamaytirish qobiliyatidir . Fitoterapiya o'tkir rinosinusit bilan og'rigan be-morlarni davolashning yaxshi alternativ usuli hisoblanadi. Rinosinusitni kompleks davolash bo'yicha ma'lumotlar keltirilgan. Shunga qaramay,o'tkir rinosinusit bilan og'rigan bemorlarni davolash uchun o'simlik dorilarining xavfsizlik va samaradorligi noaniqligicha qolmoqda. Biroq, o'simlik do-rilarining samaradorligi haqida ko'proq ma'lumot olish uchun ko’plab tadqiqotlar o’tkazish talab etiladi.

Kalit so'zlar

o'tkir rinosinusit,fitoterapiya, o'simlik dori moddalar samaradorligi.

Adabiyotlar

  1. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F. et al.EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. 2012;50(1):1–12.https://doi.org/10.4193/rhino12.000.
  2. Orlandi R.R., Kingdom T.T., Hwang P.H., Smith T.L., Alt J.A., Baroody F.M. et al. International Consensus Statement on Allergy and Rhinology: 2016;6(Suppl. 1):S22–S209.https://doi.org/10.1002/alr.21695.
  3. Бобокулова Д.Ф.(2024). Риносинуситларни даволашда доривор ўсимликларнинг аҳамияти. Spanish international scientific online conference PROSPECTS AND MAIN TRANDS IN MODERN SCIENCE.20-23.
  4. Passali D., Cambi J., Passali F.M., Bellussi L.M. Phytoneering: a new way of therapy for rhinosinusitis. Acta Otorhinolaryngol Ital. 2015;35(1):1–8.Available at: https://pubmed.ncbi.nlm.nih.gov/26015644.
  5. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. https://doi.org/10.4193/Rhin20.600.
  6. Nurov U.I., Bobokulova D.F. (2023). STUDY OF THE IMMUNOBIOLOGICAL ACTIVITY OF THE MEDICINAL HERB CELANDINE. ОБРАЗОВАНИЕ И НАУКА В XXI ВЕКЕ. №43-1,84-88.
  7. Bobokulova D.F.(2023). PHOTODYNAMIC THERAPY OF PURULENT INFLAMMATION OF THE PARAPOGEAL SINUSES. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va rivojlanish omillari. 24-to’plam noyabr 2023.172-180.
  8. Guo R., Canter P.H., Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review. Otolaryngol Head Neck Surg. 2006;135(4):496–506.https://doi.org/10.1016/j.otohns.2006.06.1254.
  9. Jund R., Mondigler M., Steindl H., Stammer H., Stierna P., Bachert C. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. 2012;50(4):417–426. https://doi.org/10.4193/rhino.12.015.
  10. Jund R., Mondigler M., Stammer H., Stierna P., Bachert C. Herbal dr ugBNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015;135(1):42–50. https://doi.org/10.3109/00016489.2014.952047.
  11. Griffin A.S., Cabot P., Wallwork B., Panizza B. Alternative therapies for chronic rhinosinusitis: A review. Ear Nose Throat J. 2020:145561320939415.22.https://doi.org/10.1177/0145561320939415.
  12. Nurov U.I., & Ikramova, F.S. (2021). Features Of Non-Specific Protection Factors And Cytokine Status In Inflammatory Diseases Of The Paranasal Sinuses In Twin Children. The American Journal of Medical Sciences and Pharmaceutical Research, 3(02), 118–126. https://doi.org/10.37547/TAJMSPR/Volume03Issue02-18
  13. Neubauer N., Marz R.W. Placebo-controlled, randomized double-blind clinical trial with Sinupret® sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine. 1994;1(3):177–181. https://doi.org/10.1016/s0944-7113(11)80061-9.
  14. Acute rhinosinusitis. Effective therapy with a 5 plant combination. MMW Fortschr Med. 2013;155(7):70–71. Available at: https://pubmed.ncbi.nlm. nih.gov/23668182.
  15. Nosulya E.V., Kim I.A., Yushkina M.A. Herbal medicine for acute sinusitis current trends. Vestn Otorinolaringol. 2021;86(1):108–111. https://doi.org/10.17116/otorino202186011108.
  16. Gottschlich S., Roschmann K., Candler H. Phytomedicines in Acute Rhinosinusitis: A Prospective, Non-interventional Parallel-Group Trial. Adv Ther. 2018;35(7):1023–1034. https://doi.org/10.1007/s12325-018-0736-7.
  17. Passali D., Loglisci M., Passali G.C., Cassano P., Rodriguez H.A., Bellussi L.M. A prospective open-label study to assess the effica-cy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2015;77(1):27–32. https://doi.org/10.1159/000370123.
  18. Popovych V.I., Beketova H.V., Koshel I.V., Tsodikova O.A., Kriuchko T.A., Abaturov A.E. et al. An open-label, multicentre, randomized comparative study of efficacy, safety and tolerability of the 5 plant – extract BNO 1012 in the Delayed Antibiotic Prescription Method in children, aged 6 to 11 years with acute viral and post-viral rhinosinusitis. Am J Otolaryn-gol.2020;41(5):102564. https://doi.org/10.1016/j.amjoto.2020.102564.
  19. Rhinitis and rhinosinusitis. Phytotherapy: avoiding resistance. MMW Fortschr Med.2014;156(1):62–63. Available at: https://pubmed.ncbi.nlm.nih.gov/24930313.
  20. Sen’kevich O.A., Sidorenko S.V., Ditrikh O.A. Comparative efficacy of various treatment regimens for children 2–5 years old with symptoms of acute viral rhinosinusitis. Vestn Otorinolaringol. 2021;86(1):46–50. https://doi.org/10.17116/otorino20218601146.
  21. Nurov, U. I., Xolov, H. N., & Umarov, U. U. (2022). Immunological Diagnosis of Severity Rhinosinusitis. Web of Scholars: Multidimensional Research Journal, 1(5), 165-167.
  22. Nurov, U. I., G. U. Nurova, and D. R. Rashidov. "THE INCIDENCE OF RHINOSINUSITIS AMONG ENT DISEASES IN SCHOOL-AGE CHILDREN." Scientific progress 3.4 (2022): 28-31.
  23. Nurova, G. U., and M. B. Shodieva. "MODERN DIAGNOSIS AND TREATMENT OF VASOMOTOR RHINITIS." Евразийский журнал медицинских и естественных наук 2.10 (2022): 79-82.
  24. Nurova, G. U. "Possibilities of modern light diagnostics in acute and chronic diseases of the nasal adjuncts." JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH 2.4 (2023): 55-58.
  25. Nurova, G. U. "The state of indicators of functional activity of neutrophils, peripheral blood monocytes and cytokine status of the body in twin children with chronic purulent rhinosinusitis." Journal of healthcare and life-science research 2.4 (2023): 53-54.
  26. Nurova, G. U. "Chronic Rhinosinusitis in Different Age Group." EUROPEAN JOURNAL OF INNOVATION IN NONFORMAL EDUCATION 3.12 (2023): 92-93.
  27. Palm J., Steiner I., Abramov-SommarivaD., Ammendola A., Mitzenheim S., Steindl H. et al. Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis. Rhinology. 2017;55(2):142–151. https://doi.org/10.4193/rhin16.103.
  28. Nurov U.I, Bobokulova D.(2023).INHALATION THERAPY FOR INFLAMMATORY DISEASES OF THE LARYNX. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va rivojlanish omillari . 24-to’plam noyabr 2023.181-186.
  29. Asher B.F., Seidman M., Snyderman C. Complementary and alternative medicine in otolaryngology. Laryngoscope. 2001;111(8):1383-1389.https://doi.org/10.1097/00005537-200108000-00013.

MAQOLALAR